Browsing Tag
ReVeRA-301
1 post
Milestone takes etripamil into Phase 3 AFib test with at-home treatment strategy
Milestone Pharmaceuticals has dosed the first patient in a pivotal Phase 3 trial testing whether etripamil nasal spray can give patients with rapid-rate atrial fibrillation an at-home alternative to emergency treatment.